Treating your patients

How the National Medical Stockpile distributes approved COVID-19 treatments to the states and territories.

State and territory governments provide access to COVID-19 treatments

The National Medical Stockpile (NMS) distributes approved COVID-19 treatments.

Your local state or territory government gives health professionals access to these treatments. Check with your local health department about their supply arrangements.

You do not need to apply to us or via a hospital.

Process for states and territories

State and territory governments access supplies by contacting the NMS. We will work through the process with them.

Clinical criteria for access

We have criteria for access to treatments.

Clinical indications for treatment

The National Clinical Evidence Taskforce has determined clinical guidelines for approved treatments. The taskforce included the guidelines in its Australian guidelines for the clinical care of people with COVID-19.

Available treatments from the NMS

The NMS has the following treatments for COVID-19 available:

  • casirivimab and imdevimab (Ronapreve)

  • sotrovimab (Xevudy)

  • remdesivir (Veklury).

Supplies are limited. We deploy them through a consistent national model.

The Science and Industry Technical Advisory Group (SITAG) advises the Australian Government on the purchasing and manufacturing of COVID-19 vaccines and treatments.

We continuously review emerging clinical trial evidence and SITAG’s advice.

Last updated:

Help us improve

If you would like a response please use the enquiries form instead.